-
公开(公告)号:US20150306251A1
公开(公告)日:2015-10-29
申请号:US14418019
申请日:2013-08-01
CPC分类号: A61K49/0004 , A61K9/0019 , A61K9/08 , A61K47/32 , A61K47/36 , A61K47/38 , A61K47/42
摘要: The present invention relates to use of albumin and a viscosity modifier, particularly a viscosity increasing agent, in a placebo.
摘要翻译: 本发明涉及在安慰剂中使用白蛋白和粘度调节剂,特别是增粘剂。
-
公开(公告)号:US20140128326A1
公开(公告)日:2014-05-08
申请号:US14075104
申请日:2013-11-08
申请人: Novozymes Biopharma DK A/S , University of OSLO , Novozymes Biopharma UK Limited , Novozymes A/S
IPC分类号: C07K14/765
CPC分类号: C07K14/765 , A61K38/385 , A61K39/385 , C07K2319/00 , C07K2319/31
摘要: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
摘要翻译: 本发明涉及亲本白蛋白的变体,该变体与母体白蛋白相比具有改变的血浆半衰期。 本发明还涉及编码这些变体的多核苷酸; 核酸构建体,载体和包含多核苷酸的宿主细胞; 以及使用这些变体的方法。
-